Clinical Trial Update: Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing telitacicept to cyclophosphamide for lupus-related interstitial lung disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Lung Disease
• Systemic Lupus Erythematosus

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Telitacicept

Snippet

Sponsor: Tongji Hospital | Conditions: Lupus or SLE, Interstitial Lung Disease | Phase 4 | Status: RECRUITING